RESTON, Va., May 28, 2014 /PRNewswire/ -- Leidos [NYSE: LDOS], a national security, health and engineering solutions company, was awarded a prime contract by the U.S. Department of Homeland Security (DHS) to support and supplement the Science and Technology (S&T) Agricultural Scientific Program at the Plum Island Animal Disease Center (PIADC). The single-award time and materials (T&M) contract has a one-year base period of performance, four one-year options and a total contract value of approximately $12 million if all options are exercised. Work will be performed in Orient Point, N.Y.
The DHS S&T mission is to strengthen America's security and resiliency by providing knowledge products and innovative technology solutions for the Homeland Security Enterprise. In support of that mission, PIADC is the only laboratory in the nation that can work on high-consequence foreign animal diseases. The laboratory helps protect U.S. livestock from the accidental or intentional introduction of foreign animal diseases. Based on the breadth of this mission, the DHS S&T Agricultural Defense Scientific Program at the PIADC is critical to the development of Foreign Animal Disease countermeasures that can be deployed in the event of an outbreak, including vaccines, diagnostic technology and biotherapeutics.
Under the contract, Leidos will support and supplement the DHS S&T Agricultural Defense Scientific Program at PIADC with planning, program management support and oversight for the development of vaccines, diagnostics and other countermeasures to mitigate the impact of Foreign Animal Diseases.
The PIADC program continues Leidos Health's three decades of work in Life Sciences supporting the integration of large biomedical research and development, logistical and administrative support services for federal scientific, biopharmaceutical and agricultural programs. From supporting ground-breaking medical research to optimizing business operations, the Life Sciences team designs and delivers customized solutions to expedite the discovery and development of safe and effective medical treatments and scientific advances.
"We are pleased to continue our support to the DHS S&T Directorate to protect U.S. livestock from foreign animal diseases that can seriously threaten our livestock industries, economy, and way of life," said President of Leidos Health, Steve Comber.
Leidos is a science and technology solutions leader working to address some of the world's toughest challenges in national security, health and engineering. The Company's 22,000 employees support vital missions for our government and the commercial sector, develop innovative solutions to drive better outcomes, and defend our Nation's digital and physical infrastructure from 'new world' threats. Headquartered in Reston, Va., Leidos reported annual revenues of approximately $5.77 billion for its fiscal year ended January 31, 2014, after giving effect to the spin-off of the company's technical services and information technology business. For more information, visit www.Leidos.com.
Statements in this announcement, other than historical data and information, constitute forward-looking statements that involve risks and uncertainties. A number of factors could cause our actual results, performance, achievements, or industry results to be very different from the results, performance, or achievements expressed or implied by such forward-looking statements. Some of these factors include, but are not limited to, the risk factors set forth in the company's Annual Report on Form 10-K for the period ended January 31, 2014, and other such filings that Leidos makes with the SEC from time to time. Due to such uncertainties and risks, readers are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof.